Our Mission
Axonis Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system.
Scientific Advisory Board
![](https://axonis.us/wp-content/uploads/2024/05/Yves-De-Konick-10-2023-BW.jpg)
YVES DE KONINCK, Ph.D.
Chair of Scientific Advisory Board
![](https://axonis.us/wp-content/uploads/2011/06/Corey-Goodman-onwhite-1.jpg)
COREY GOODMAN, Ph.D.
Executive Chairman, Co-Founder & Scientific Advisor
![](https://axonis.us/wp-content/uploads/2022/10/Zhigang_He__1_-removebg-preview-1-1-e1666281313307.png)
ZHIGANG HE, Ph.D.
Scientific Advisor, KCC2 Neurobiology
![](https://axonis.us/wp-content/uploads/2022/06/clifford-woolf-bw-removebg.jpg)
CLIFFORD WOOLF, Ph.D.
Scientific Advisor, Pain
![](https://axonis.us/wp-content/uploads/2024/05/Jacqueline-French-BW-1.png)
JACQUELINE FRENCH, M.D.
Scientific Advisor, Clinical Epilepsy
![](https://axonis.us/wp-content/uploads/2024/05/roger-porter-1.png)
ROGER PORTER, M.D.
Scientific Advisor, Epilepsy & Clinical Pharmacology
![](https://axonis.us/wp-content/uploads/2019/07/Lisa-McKerracher-2.jpg)
LISA MCKERRACHER, Ph.D.
Scientific Advisor & Co-Founder
![](https://axonis.us/wp-content/uploads/2022/06/James-Guest-bw-whiteback.jpg)
JAMES GUEST, M.D., Ph.D., FACS
Scientific Advisor, Clinical Spinal Cord Injury